Author:
Hanamura Toru,Niwa Toshifumi,Nishikawa Sayo,Konno Hiromi,Gohno Tatsuyuki,Tazawa Chika,Kobayashi Yasuhito,Kurosumi Masafumi,Takei Hiroyuki,Yamaguchi Yuri,Ito Ken-ichi,Hayashi Shin-ichi
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Andò S, De Amicis F, Rago V, Carpino A, Maggiolini M, Panno ML, Lanzino M (2002) Breast cancer: from estrogen to androgen receptor. Mol Cell Endocrinol 193:121–128
2. Chia S, Gradishar W, Mauriac L, Bines J, Amant F, Federico M, Fein L, Romieu G, Buzdar A, Robertson JF et al (2008) Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT. J Clin Oncol 26:1664–1670
3. Chlebowski R, Cuzick J, Amakye D, Bauerfeind I, Buzdar A, Chia S, Cutuli B, Linforth R, Maass N, Noguchi S et al (2000) Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer. The Breast 18(Suppl 2):S1–S11
4. Fang H, Tong W, Branham WS, Moland CL, Dial SL, Hong H, Xie Q, Perkins R, Owens W, Sheehan DM (2003) Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol 16:1338–1358
5. Hayashi S, Niwa T, Yamaguchi Y (2009) Estrogen signaling pathway and its imaging in human breast cancer. Cancer Sci 100:1773–1778
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献